PDCD1 (PD-1) was strongly associated with tumor mutation burden (TMB), microsatellite instability (MSI), and immune cell infiltration, and it can be used as a prognostic marker in several cancer types (Miao et al., 2020). This evidence concerns the gene PDCD1 and cancer.